MIRA Pharmaceuticals, Inc. (MIRA) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering MIRA Pharmaceuticals, Inc. (MIRA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For MIRA Pharmaceuticals, Inc., the average estimate for 2030 earnings per share is −$0.21; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
MIRA Pharmaceuticals, Inc. (MIRA) forecast — frequently asked questions
What are analysts forecasting for MIRA Pharmaceuticals, Inc.'s earnings?
The average analyst estimate for MIRA Pharmaceuticals, Inc. (MIRA) earnings per share in 2030 is -0.21, with individual estimates between -0.21 and -0.21.
How much revenue is MIRA Pharmaceuticals, Inc. expected to make?
Analysts forecast MIRA Pharmaceuticals, Inc. (MIRA) revenue of $0 in 2030, based on 1 published estimates.
How many analysts cover MIRA?
1 analyst contribute estimates for MIRA Pharmaceuticals, Inc. (MIRA). Thin coverage makes an average less reliable.
Analyst forecasts for other Drug Manufacturers - General stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.